NASDAQ:CPIX
Cumberland Pharmaceuticals Inc. Stock News
$1.70
+0.0900 (+5.59%)
At Close: Apr 25, 2024
Cumberland Pharmaceuticals Inc. (CPIX) Q4 2023 Earnings Call Transcript
10:06pm, Tuesday, 05'th Mar 2024
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q4 2023 Earnings Conference Call March 5, 2024 4:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A. J. Kazimi - Chairman an
Cumberland Pharmaceuticals Inc. (CPIX) Q3 2023 Earnings Call Transcript
08:17am, Saturday, 11'th Nov 2023
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A. J. Kazimi - Chairman
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS
04:05pm, Tuesday, 31'st Oct 2023
NASHVILLE, Tenn., Oct. 31, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceuticals company, announced today that it will release the third quarter 2023 financ
Cumberland Pharmaceuticals Inc. (CPIX) Q2 2023 Earnings Call Transcript
04:21am, Saturday, 12'th Aug 2023
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET Company Participants Molly Aggas - IR A.J. Kazimi - CEO Todd Anthony - VP, Organizational Deve
Cumberland Pharmaceuticals Inc. (CPIX) Q1 2023 Earnings Call Transcript
05:45pm, Saturday, 13'th May 2023
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q1 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company Participants Julia Motis - Senior Account Manager, Dalton Agency A.J. Kazimi - CEO Todd A
Cumberland Pharmaceuticals Inc. (CPIX) Q4 2022 Earnings Call Transcript
10:47pm, Tuesday, 07'th Mar 2023
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q4 2022 Earnings Conference Call March 7, 2023 4:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A.J. Kazimi - CEO Todd Ant
Cumberland Pharmaceuticals, Inc. (CPIX) Q3 2022 Earnings Call Transcript
08:53pm, Saturday, 12'th Nov 2022
Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A. J. Kazimi - Founder
What Happened This Week: FedEx, The ‘Merge’ And Some Mighty Big Losers
01:25pm, Saturday, 17'th Sep 2022 Investing.com
$3 Million Bet On This Communication Services Stock? Check Out These 4 Penny Stocks Insiders Are Buying
03:08pm, Monday, 22'nd Aug 2022 Benzinga
The Dow Jones dropped more than 290 points on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern arou
Cumberland Pharmaceuticals Inc. (CPIX) CEO A.J. Kazimi on Q2 2022 Results - Earnings Call Transcript
02:07pm, Saturday, 13'th Aug 2022
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q2 2022 Results Conference Call August 9, 2022 4:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A.J. Kazimi - Chief Execut
Cumberland Pharmaceuticals Inc. (CPIX) CEO A.J. Kazimi on Q1 2022 Results - Earnings Call Transcript
05:42pm, Saturday, 14'th May 2022
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q1 2022 Results Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A.J. Kazimi - Chief
Cumberland Pharmaceuticals Inc.''s (CPIX) CEO A.J. Kazimi on Q4 2021 Results - Earnings Call Transcript
04:08am, Wednesday, 09'th Mar 2022 Seeking AlphaCumberland Pharmaceuticals Inc.'s (CPIX) CEO A.J. Kazimi on Q4 2021 Results - Earnings Call Transcript
11:08pm, Tuesday, 08'th Mar 2022
Cumberland Pharmaceuticals Inc.'s (CPIX) CEO A.J. Kazimi on Q4 2021 Results - Earnings Call Transcript
Cumberland Pharmaceuticals GAAP EPS of -$0.29 misses by $0.26, revenue of $8.3M misses by $32.67M
09:43pm, Tuesday, 08'th Mar 2022 Seeking Alpha
Cumberland Pharmaceuticals press release (CPIX): FY GAAP EPS of -$0.29 misses by $0.26.Revenue of $8.3M (-19.1% Y/Y) misses by $32.67M.
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2021 FINANCIAL RESULTS
09:05pm, Tuesday, 01'st Mar 2022 PR Newswire
NASHVILLE, Tenn., March 1, 2022 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceuticals company, announced today that it will release annual 2021 financial results and provide a company update after the market closes on Tuesday, March 8, 2022. A…
